Therefore, we proposed a retrospective analysis of a prospective cohort exploring the connection between the plasma ET‐1 levels and poor prognostic outcomes in two study populations including CAD patients undergoing PCI with impaired kidney function in different diabetes statuses and CAD patients undergoing PCI with DM in various kidney functions, respectively. This evidence concerns the gene EDN1 and coronary artery disorder.